Safety and Efficacy of Longterm HPN With Two Lipid Emulsions
NCT00530738 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2014-07-18
Summary
It is the purpose of this trial to provide evidence for safety and efficacy of long term home parenteral nutrition with either Lipofundin MCT or Lipoplus in patients with proven insufficient enteral resorption.
Conditions
- Malnutrition
Interventions
- DRUG
-
Lipoplus
i.v. fat emulsion for parenteral nutrition
- DRUG
-
Lipofundin MCT
i.V. fat emulsion for parenteral nutrition
Sponsors & Collaborators
-
B. Braun Melsungen AG
lead INDUSTRY
Principal Investigators
-
Paul Thul, MD · Charité, University Hospital Berlin
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2014-01-31
- Completion
- 2014-01-31
Countries
- Germany
Study Locations
More Related Trials
-
Feasibility Study to Evaluate Safety of Nutriseal™ Nutriplace™ System
NCT03371160 ·Status: TERMINATED ·Phase: NA
-
To Study the Effects of Lipid Emulsion on Hemodynamics in Organophosphate Compound Poisoning
NCT03564574 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT06842134 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
NCT02784392 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation
NCT01579097 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
NCT00672854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis
NCT01571297 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT
NCT02338440 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
NCT00172185 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates
NCT01360372 ·Status: WITHDRAWN ·Phase: PHASE3
-
Evaluation of a Connected Parenteral Pump for Patients Treated by Home Parenteral Nutrition (HPN).
NCT04406766 ·Status: TERMINATED ·Phase: NA
-
Nutritional Tolerance and Safety of a Tube Feeding Formula
NCT05848583 ·Status: TERMINATED ·Phase: NA
-
Intravenous Nutrition in Hospitalized Patients: Comparison of Two Oils
NCT01943409 ·Status: COMPLETED ·Phase: PHASE4
-
Temporary Gastric Electrical Stimulation for Drug Refractory Gastroparesis
NCT00432835 ·Status: COMPLETED ·Phase: PHASE3
-
IV Glucose for Dehydration Treatment
NCT01285713 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Teduglutide on Gastric Emptying in Healthy Subjects
NCT01209351 ·Status: COMPLETED ·Phase: PHASE1
-
Timing of Initiation of Parenteral Nutrition for Critically Ill Children
NCT04693143 ·Status: UNKNOWN ·Phase: NA
-
Pharyngeal Electrical Stimulation for the Treatment of Post-extubation Dysphagia in Acute Stroke
NCT02470078 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
NCT04303195 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of 70% Ethanol Lock Solution to Prevent Catheter Related Blood Stream Infections in Pediatric Patients
NCT01409772 ·Status: WITHDRAWN
-
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
NCT02375217 ·Status: COMPLETED ·Phase: PHASE4
-
Plasma Exchange for Amanita Toxin-induced Acute Liver Failure
NCT06187220 ·Status: COMPLETED
-
Evaluation of FDY-5301 in Major Trauma Patients in ICU
NCT04430283 ·Status: TERMINATED ·Phase: PHASE2